Moderna Q3 earnings: Stock falls as vaccine outlook disappoints

Shares of the Cambridge vaccine maker fell Thursday morning as the company adjusted its 2023 vaccine outlook to the lower end of its previous forecast as it reported its third-quarter earnings.